Australia Point of care (PoC) Molecular Diagnostics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Point of care (PoC) Molecular Diagnostics is expanding as a result of growing prevalence of chronic and infectious diseases. This demand is boosting the growth of development of better diagnostic tools and methods for the molecular point of care. Some of the key players in the global Point of Care (PoC) Molecular Diagnostics Market include Abbott Laboratories, Danher Corporation, Hoffmann-La Roche Ltd., BioMerieux, Quidel Corporation, QIAGEN N.V., Co-Diagnostics, Inc., Biocartis NV, Meridian Bioscience, Inc., and Thermo Fisher Scientific, Inc.
Australia Point Of Care (PoC) Molecular Diagnostic Market is valued at around $40.8 Bn in 2022 and is projected to reach $107.7 Bn by 2030, exhibiting a CAGR of 12.9% during the forecast period 2023-2030.
The Point of Care (PoC) Molecular Diagnostics Market refers to the market for tools and methods used for diagnosis performed near the patient. The market includes non-specialists like nurses and doctors to perform the test in various clinical settings for early and accurate detection of diseases.
The increased prevalence of chronic and infectious diseases will contribute to the growth of the global market for Point of Care (PoC) Molecular diagnostic services. Advances in diagnostic technologies such as DNA sequencing are also driving the market.
Pharmaceutical and biotechnology firms like Abbott Laboratories, Danaher Corporation, Hoffmann-La Roche Ltd., BioMerieux, Quidel Corporation, QIAGEN N.V., Co-Diagnostics, Inc., Biocartis NV, Meridian Bioscience, Inc., and Thermo Fisher Scientific, Inc., are some of the major players in the Point of care (PoC) Molecular Diagnostics Market.
Point of Care (PoC) Molecular Diagnostics has improved patient care in different clinical settings like homes, research centers, and healthcare settings in rural areas and accelerated diagnosis of cardiovascular diseases.
Quick diagnosis and improved standard of care have been possible with Point of Care (PoC) Molecular diagnostics which helps physicians with easy treatment decisions during a patient’s first visit.
Drivers of Australia Point of Care (PoC) Molecular Diagnostics Market:
Growing Incidence and Prevalence of Chronic and Infectious Diseases: Increase in chronic and infectious diseases will boost the market for Point of Care (PoC) Molecular Diagnostics as there will be more consumption of these services for the early and accurate detection of diseases.
Increasing Research & Development Funding: Investment in research & development will ensure better and improved diagnostic techniques which will raise the demand for Point of Care (PoC) Molecular Diagnostic services.
Technological Advancements: Advancements in technology like DNA sequencing are driving the market for Point of Care (PoC) Molecular Diagnostics.
Growing Awareness about Pre-disease Diagnostics: Pre-disease diagnostics is prevalent among people to control the occurrence of diseases which is growing the Point of Care (PoC) Molecular Diagnostics Market.
In 2022, Sense Biodetection entered a strategic agreement with Una Health for the distribution of the Veros COVID-19 test.
Key players
Abbott Laboratories Roche Diagnostics Cepheid Quidel Corporation BioM?rieux Thermo Fisher Scientific Hologic, Inc. Danaher Corporation GenMark Diagnostics Luminex Corporation1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Product
By Technology
By Application
By End-user
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.